微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 70.95% | 3.29% | 1.99% | 20/141 | 52.4% | 佰仁医疗 | 88.71% | 行业排名> |
| 2026-03-31 | 69.57% | 1.83% | -0.39% | 25/141 | 52.37% | 佰仁医疗 | 88.17% | 行业排名> |
| 2025-12-31 | 69.84% | 0.87% | 0.9% | 25/141 | 51.9% | 佰仁医疗 | 89.18% | 行业排名> |
| 2025-09-30 | 69.22% | -0.86% | 0.76% | 26/141 | 52.23% | 佰仁医疗 | 88.17% | 行业排名> |
| 2025-06-30 | 68.7% | -0.53% | 0.56% | 27/141 | 52.48% | 佰仁医疗 | 88.54% | 行业排名> |
| 2025-03-31 | 68.32% | -1.06% | -1.33% | 27/141 | 52.13% | 佰仁医疗 | 85.72% | 行业排名> |
| 2024-12-31 | 69.24% | 0.21% | -0.84% | 29/141 | 53.08% | 佰仁医疗 | 88.34% | 行业排名> |
| 2024-09-30 | 69.82% | 0.41% | 1.1% | 27/141 | 53.87% | 佰仁医疗 | 88.56% | 行业排名> |
| 2024-06-30 | 69.06% | 0.4% | 0.02% | 33/141 | 53.95% | 佰仁医疗 | 89.27% | 行业排名> |
| 2024-03-31 | 69.05% | 0.62% | -0.06% | 33/141 | 53.88% | 佰仁医疗 | 89.28% | 行业排名> |
| 2023-12-31 | 69.09% | 2.13% | -0.63% | 28/141 | 53.57% | 正海生物 | 89.9% | 行业排名> |
| 2023-09-30 | 69.53% | 0.32% | 1.09% | 27/141 | 54.44% | 正海生物 | 90.39% | 行业排名> |
| 2023-06-30 | 68.78% | 1.09% | 0.23% | 31/141 | 53.81% | 正海生物 | 90.3% | 行业排名> |
| 2023-03-31 | 68.62% | 2.11% | 1.44% | 31/141 | 54.06% | 万泰生物 | 91.61% | 行业排名> |
| 2022-12-31 | 67.65% | -2.78% | -2.39% | 36/141 | 54.01% | 三友医疗 | 90.18% | 行业排名> |
| 2022-09-30 | 69.31% | 0.23% | 1.86% | 32/141 | 55.7% | 三友医疗 | 90.14% | 行业排名> |
| 2022-06-30 | 68.04% | -2.79% | 1.24% | 36/141 | 55.37% | 三友医疗 | 90.29% | 行业排名> |
| 2022-03-31 | 67.21% | -2.31% | -3.42% | 38/141 | 56.89% | 三友医疗 | 90.73% | 行业排名> |
| 2021-12-31 | 69.58% | 4.6% | 0.63% | 37/141 | 57.98% | 三友医疗 | 90.5% | 行业排名> |
| 2021-09-30 | 69.15% | 4.24% | -1.21% | 34/141 | 59.77% | 三友医疗 | 90.29% | 行业排名> |
| 2021-06-30 | 69.99% | 6.86% | 1.75% | 40/141 | 59.05% | 正海生物 | 90.78% | 行业排名> |
| 2021-03-31 | 68.79% | 6.99% | 3.4% | 39/141 | 61.5% | 正海生物 | 91.59% | 行业排名> |
| 2020-12-31 | 66.53% | -1.65% | 0.29% | 51/141 | 60.12% | 正海生物 | 92.23% | 行业排名> |
| 2020-09-30 | 66.33% | -5.35% | 1.27% | 36/141 | 62.21% | 正海生物 | 92.69% | 行业排名> |
| 2020-06-30 | 65.5% | -5.85% | 1.88% | 45/141 | 60.36% | 正海生物 | 92.61% | 行业排名> |
| 2020-03-31 | 64.29% | -8.36% | -4.95% | 32/141 | 58.8% | 正海生物 | 94.38% | 行业排名> |
| 2019-12-31 | 67.64% | 1.71% | -3.48% | 44/141 | 56.96% | 正海生物 | 93.12% | 行业排名> |
| 2019-09-30 | 70.09% | 0.67% | 0.74% | 18/141 | 55.83% | 正海生物 | 93.78% | 行业排名> |
| 2019-06-30 | 69.57% | 0.43% | -0.83% | 25/141 | 57.93% | 正海生物 | 93.09% | 行业排名> |
| 2019-03-31 | 70.16% | 2.94% | 5.49% | 14/141 | 52.61% | 正海生物 | 93.85% | 行业排名> |
| 2018-12-31 | 66.51% | -0.68% | -4.47% | 41/141 | 56.22% | 正海生物 | 93.08% | 行业排名> |
| 2018-09-30 | 69.62% | 2.8% | 0.5% | 14/141 | 52.76% | 正海生物 | 92.83% | 行业排名> |
| 2018-06-30 | 69.27% | 1.38% | 1.64% | 17/141 | 53.06% | 正海生物 | 92.44% | 行业排名> |
| 2018-03-31 | 68.15% | 2.91% | 1.78% | 16/141 | 52.55% | 正海生物 | 92.7% | 行业排名> |
| 2017-12-31 | 66.96% | 3.34% | -1.12% | 41/141 | 56.1% | 正海生物 | 93.67% | 行业排名> |
| 2017-09-30 | 67.72% | 2.62% | -0.89% | 14/141 | 53.53% | 正海生物 | 94.14% | 行业排名> |
| 2017-06-30 | 68.33% | 3.96% | 3.17% | 19/141 | 54.85% | 正海生物 | 93.83% | 行业排名> |
| 2017-03-31 | 66.23% | 4.24% | 2.2% | 15/141 | 54.29% | 正海生物 | 93.69% | 行业排名> |
| 2016-12-31 | 64.8% | -0.91% | -1.8% | 32/141 | 57.35% | 正海生物 | 92.79% | 行业排名> |
| 2016-09-30 | 65.99% | -2.71% | 0.4% | 10/141 | 51.85% | 健帆生物 | 84.23% | 行业排名> |
| 2016-06-30 | 65.73% | -6.42% | 3.45% | 16/141 | 52.6% | *ST明德 | 86.71% | 行业排名> |
| 2016-03-31 | 63.53% | -5.16% | -2.85% | 8/141 | 50.24% | 健帆生物 | 83.86% | 行业排名> |